252 related articles for article (PubMed ID: 32146615)
1. Association between comorbidities and extraglandular manifestations in primary Sjögren's syndrome: a multicenter cross-sectional study.
Zhang Y; Li M; Zhang L; Li Q; Yang P; Kong X; Duan X; Zhang M; Li X; Wang Y; Xu J; Wang Y; Hsieh E; Zhao J; Xu D; Zhao Y; Zeng X
Clin Rheumatol; 2020 Sep; 39(9):2677-2688. PubMed ID: 32146615
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED
Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929
[TBL] [Abstract][Full Text] [Related]
3. Renal tubular acidosis and associated factors in patients with primary Sjögren's syndrome: a registry-based study.
Zhang Y; Qiao L; Zhang L; Li Q; Yang P; Kong X; Duan X; Zhang M; Li X; Wang Y; Xu J; Wang Y; Hsieh E; Zhao J; Xu D; Li M; Zhao Y; Zeng X
Clin Rheumatol; 2023 Feb; 42(2):431-441. PubMed ID: 36383239
[TBL] [Abstract][Full Text] [Related]
4. Anxiety and depression in primary Sjögren's syndrome: a cross-sectional study.
Cui Y; Xia L; Li L; Zhao Q; Chen S; Gu Z
BMC Psychiatry; 2018 May; 18(1):131. PubMed ID: 29769121
[TBL] [Abstract][Full Text] [Related]
5. Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients.
Baldini C; Pepe P; Quartuccio L; Priori R; Bartoloni E; Alunno A; Gattamelata A; Maset M; Modesti M; Tavoni A; De Vita S; Gerli R; Valesini G; Bombardieri S
Rheumatology (Oxford); 2014 May; 53(5):839-44. PubMed ID: 24369420
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of primary Sjögren's syndrome in female patients with thyroid disorders: a longitudinal population-based study in Taiwan.
Lu MC; Yin WY; Tsai TY; Koo M; Lai NS
PLoS One; 2013; 8(10):e77210. PubMed ID: 24204772
[TBL] [Abstract][Full Text] [Related]
8. Comorbidities in patients with primary Sjogren's syndrome: a registry-based case-control study.
Kang JH; Lin HC
J Rheumatol; 2010 Jun; 37(6):1188-94. PubMed ID: 20360180
[TBL] [Abstract][Full Text] [Related]
9. Ten-year observation of patients with primary Sjögren's syndrome: Initial presenting characteristics and the associated outcomes.
Tsukamoto M; Suzuki K; Takeuchi T
Int J Rheum Dis; 2019 May; 22(5):929-933. PubMed ID: 30588773
[TBL] [Abstract][Full Text] [Related]
10. Childhood-onset primary Sjögren's syndrome in a tertiary center in China: clinical features and outcome.
Gong Y; Liu H; Li G; Zhang T; Li Y; Guan W; Zeng Q; Lv Q; Zhang X; Yao W; Shi Y; Xu H; Sun L
Pediatr Rheumatol Online J; 2023 Jan; 21(1):11. PubMed ID: 36707855
[TBL] [Abstract][Full Text] [Related]
11. Incident cases of primary Sjögren's syndrome during a 5-year period in Stockholm County: a descriptive study of the patients and their characteristics.
Kvarnström M; Ottosson V; Nordmark B; Wahren-Herlenius M
Scand J Rheumatol; 2015; 44(2):135-42. PubMed ID: 25222653
[TBL] [Abstract][Full Text] [Related]
12. Comorbidities (excluding lymphoma) in Sjögren's syndrome.
Pego-Reigosa JM; Restrepo Vélez J; Baldini C; Rúa-Figueroa Fernández de Larrinoa Í
Rheumatology (Oxford); 2021 May; 60(5):2075-2084. PubMed ID: 30770715
[TBL] [Abstract][Full Text] [Related]
13. Higher risk of dementia in primary Sjogren's syndrome.
Hou TY; Hsu HC; Lin TM; Chang YS; Chen WS; Kuo PI; Lin YC; Chang CC; Chen JH
Ann Clin Transl Neurol; 2019 Apr; 6(4):633-641. PubMed ID: 31019988
[TBL] [Abstract][Full Text] [Related]
14. Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.
Rúa-Figueroa I; Fernández Castro M; Andreu JL; Sanchez-Piedra C; Martínez-Taboada V; Olivé A; López-Longo J; Rosas J; Galindo M; Calvo-Alén J; Fernández-Nebro A; Alonso F; Rodríguez-Lozano B; Alberto García Vadillo J; Menor R; Narváez FJ; Erausquin C; García-Aparicio Á; Tomero E; Manrique-Arija S; Horcada L; Uriarte E; Gil S; Blanco R; López-González R; Boteanu A; Freire M; Galisteo C; Rodríguez-Gómez M; Díez-Álvarez E; Pego-Reigosa JM;
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):38-45. PubMed ID: 27564390
[TBL] [Abstract][Full Text] [Related]
15. Comorbidities in the UK Primary Sjögren's Syndrome Registry.
Tarn J; Lendrem D; Barnes M; Casement J; Ng WF
Front Immunol; 2022; 13():864448. PubMed ID: 35603172
[TBL] [Abstract][Full Text] [Related]
16. Risk of Cardiovascular Involvement in Patients with Primary Sjögren's Syndrome: a large-scale cross-sectional cohort study.
Cai X; Luo J; Wei T; Qin W; Wang X; Li X
Acta Reumatol Port; 2019; 44(1):71-77. PubMed ID: 31249278
[TBL] [Abstract][Full Text] [Related]
17. Difference in clinical presentation between women and men in incident primary Sjögren's syndrome.
Ramírez Sepúlveda JI; Kvarnström M; Brauner S; Baldini C; Wahren-Herlenius M
Biol Sex Differ; 2017; 8():16. PubMed ID: 28507729
[TBL] [Abstract][Full Text] [Related]
18. Psychological comorbidities associated with subclinical atherosclerosis in Greek patients with primary Sjögren's syndrome: a potential contribution of sleep impairment.
Karageorgas T; Ioakeimidis D; Mavragani CP
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):68-72. PubMed ID: 29148412
[TBL] [Abstract][Full Text] [Related]
19. Subclinical atherosclerosis in primary Sjögren's syndrome: comparable risk with diabetes mellitus.
Zhang Y; Luo Q; Lu K; You M; Wang H
Clin Rheumatol; 2023 Jun; 42(6):1607-1614. PubMed ID: 36813944
[TBL] [Abstract][Full Text] [Related]
20. Criteria sets for primary Sjogren's syndrome are not adequate for those presenting with extraglandular organ involvements as their dominant clinical features.
Kabasakal Y; Kitapçıoğlu G; Karabulut G; Tezcan M; Balkarlı A; Aksoy A; Yavuz Ş; Yılmaz S; Kaşifoğlu T; Kalyoncu U; Dalkılıç E; Tufan A; Mercan R; Yıldız F; Şentürk T; Önen F; Bes C; Erken E; Tunç E; Kamalı S; Tarhan E; Yazıcı A; Düzgün N; Bıçakçıgil M; Yılmaz S; Özmen M; Öcal L; Alibaz-Öner F; Solmaz D; Çobankara V; Nalbant S; Kasapoğlu Günal E; Kaşkari D; Göker B
Rheumatol Int; 2017 May; 37(5):675-684. PubMed ID: 28289872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
